Improving heart failure diagnosis and treatment in Uganda using echocardiography training and medical therapy guidelines.
Optimization of echocardiography training and guideline-directed medical therapy for heart failure within a digital-first self-care program in Uganda
This study is working to improve how heart failure is diagnosed and treated in Uganda by training local healthcare workers to use ultrasound technology and looking at how medications are prescribed, all to help patients get better care.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-11090157 on NIH RePORTER |
What this research studies
This research focuses on enhancing the diagnosis and treatment of heart failure in Uganda, where resources are limited and the prevalence is high. It aims to develop a training program for non-specialists in echocardiography across six Regional Referral Hospitals, utilizing advanced AI to improve early identification and management of heart failure. Additionally, the study will analyze prescribing trends of guideline-directed medical therapy among symptomatic heart failure patients to understand and improve treatment practices. By combining training with data analysis, the project seeks to establish sustainable healthcare practices that address disparities in heart failure care.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals in Uganda experiencing symptoms of heart failure.
Not a fit: Patients outside of Uganda or those without symptoms of heart failure may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnosis and treatment outcomes for heart failure patients in Uganda.
How similar studies have performed: Previous research has shown success in enhancing healthcare delivery through training programs and guideline adherence, indicating a promising approach for this project.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Schwartz, Jeremy Ian — Yale University
- Study coordinator: Schwartz, Jeremy Ian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.